Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia - PubMed (original) (raw)

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

C J Mann et al. J Clin Invest. 1991 Dec.

Abstract

Plasma net cholesteryl ester (CE) transfer and optimum cholesteryl ester transfer protein (CETP) activity were determined in primary hypertriglyceridemic (n = 11) and normolipidemic (n = 15) individuals. The hypertriglyceridemic group demonstrated threefold greater net CE transfer leading to enhanced accumulation of CE in VLDL. This increased net transfer was not accompanied by a change in CETP activity. In normolipidemia, but not in hypertriglyceridemia, net CE transfer correlated with VLDL triglyceride (r = 0.92, P less than 0.001). In contrast, net CE transfer in hypertriglyceridemia, but not in normolipidemia, correlated with CETP activity (r = 0.73, P less than 0.01). Correction of hypertriglyceridemia with bezafibrate reduced net CE transfer towards normal and restored the correlation with VLDL triglyceride (r = 0.90, P less than 0.005) while suppressing the correlation with CETP activity. That net CE transfer depends on VLDL concentration was confirmed by an increase of net CE transfer in normolipidemic plasma supplemented with purified VLDL. Supplementation of purified CETP to normolipidemic plasma did not stimulate net CE transfer. In contrast, net CE transfer was enhanced by addition of CETP to both plasma supplemented with VLDL and hypertriglyceridemic plasma. Thus, in normal subjects, VLDL concentration determines the rate of net CE transfer. CETP becomes rate limiting as VLDL concentration increases, i.e., in hypertriglyceridemia.

PubMed Disclaimer

Cited by

Non-fasting Changes in Blood Lipids After Three Daily Meals Within a Day in Chinese Inpatients With Cardiovascular Diseases.
Tan Y, Lin Q, Xu J, Zhu L, Guo L, Xie Y, Du X, Zhang S, Wen T, Liu L. Tan Y, et al. Front Cardiovasc Med. 2022 Apr 12;9:799300. doi: 10.3389/fcvm.2022.799300. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35498036 Free PMC article.
Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia.
Föger B, Drexel H, Hopferwieser T, Miesenböck G, Ritsch A, Lechleitner M, Tröbinger G, Patsch JR. Föger B, et al. Clin Investig. 1994 Mar;72(4):294-301. doi: 10.1007/BF00180044. Clin Investig. 1994. PMID: 8043977 Clinical Trial.
Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men.
Williams PT, Krauss RM, Stefanick ML, Vranizan KM, Wood PD. Williams PT, et al. Metabolism. 1994 May;43(5):655-63. doi: 10.1016/0026-0495(94)90210-0. Metabolism. 1994. PMID: 8177056 Free PMC article. Clinical Trial.
Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglycerides.
Joseph J, Shamburek RD, Cochran EK, Gorden P, Brown RJ. Joseph J, et al. J Clin Endocrinol Metab. 2014 Sep;99(9):E1676-80. doi: 10.1210/jc.2014-1878. Epub 2014 Jun 13. J Clin Endocrinol Metab. 2014. PMID: 24926953 Free PMC article. Clinical Trial.
Postprandial lipemia and cardiovascular disease.
Hyson D, Rutledge JC, Berglund L. Hyson D, et al. Curr Atheroscler Rep. 2003 Nov;5(6):437-44. doi: 10.1007/s11883-003-0033-y. Curr Atheroscler Rep. 2003. PMID: 14525676 Review.

References

1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
1. Circulation. 1977 May;55(5):767-72 - PubMed
1. Arterioscler Thromb. 1991 Jul-Aug;11(4):797-804 - PubMed
1. J Biol Chem. 1991 Jun 15;266(17):10796-801 - PubMed
1. J Biol Chem. 1988 Sep 5;263(25):12235-41 - PubMed

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia - PubMed (original) (raw)